Ticker Details
ImmunityBio, Inc. Common Stock
IPO Date:	July 27, 2015
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$8.57B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.25 | 4.48%
Avg Daily Range (30 D):	$0.44 | 7.53%
Avg Daily Range (90 D):	$0.20 | 4.67%

Institutional Daily Volume
Avg Daily Volume:	5.09M
Avg Daily Volume (30 D):	49.28M
Avg Daily Volume (90 D):	23.48M

Trade Size
Avg Trade Size (Sh.):	254
Avg Trade Size (Sh.) (30 D):	339
Avg Trade Size (Sh.) (90 D):	360

Institutional Trades
Total Institutional Trades:	1,604
Avg Institutional Trade:	$1.83M
Avg Institutional Trade (30 D):	$1.63M
Avg Institutional Trade (90 D):	$1.67M
Avg Institutional Trade Volume:	.38M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.02M
Avg Closing Trade (30 D):	$5.66M
Avg Closing Trade (90 D):	$2.99M
Avg Closing Volume:	409.1K

News

Feb 20, 2026 @ 2:05 PM ImmunityBio Taps 85-Person Sales Team to Launch It... Source: Vandana Singh

Feb 18, 2026 @ 10:17 PM Stock Market Today, Feb. 18: ImmunityBio Soars Aft... Source: Josh Kohn-Lindquist

Feb 17, 2026 @ 4:17 PM New Treatment Modalities Are Reaching Cancers That... Source: Prnewswire

Feb 13, 2026 @ 8:32 PM Top 10 Most Shorted Stocks: CleanSpark, Hims & Her... Source: Erica Kollmann

Feb 3, 2026 @ 6:00 PM INVESTOR ALERT: Pomerantz Law Firm Reminds Investo... Source: Pomerantz Llp

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.07	$-.1	$-.15
Diluted EPS	$-.07	$-.1	$-.15
Revenue	$32.06M	$26.43M	$16.52M
Gross Profit	$31.88M	$26.29M	$16.46M
Net Income / Loss	$-67.27M	$-92.57M	$-129.67M
Operating Income / Loss	$-55.63M	$-71.29M	$-64.43M
Cost of Revenue	$.18M	$.14M	$.06M
Net Cash Flow	$-76.75M	$76.92M	$-82.76M
PE Ratio